New clinical trial data shows that additional options may soon become available for patients with melanoma for whom immunotherapy did…

…doctor. Ask a Melanoma Expert AIM at Melanoma knows a melanoma diagnosis can be confusing, but you don’t have to…

…Oncologist Medical Director, Providence Melanoma Program Providence Cancer Institute 10:40 AM PT Emerging Neoadjuvant and Adjuvant Therapies for Locally Advanced…

…history of melanoma in your family? Have you been diagnosed with melanoma? Do you have any large moles (diameter more…

…AIM launched the International Melanoma Working Group, a global collaboration of 25+ of the world’s leading experts in melanoma, who…

…This presentation is offered in person and virtually at University of Colorado, Cancer Center and Center for Rare Melanoma for…

…with AIM at Melanoma provides your DIGA chapter an exceptional opportunity to elevate melanoma awareness and champion preventive actions. By…

Replimune Announces Positive Topline Primary Analysis Data by Independent Central Review from IGNYTE Clinical Trial of RP1 plus Nivolumab in…

…approved for use in melanoma, no successful approach to treating advanced melanoma existed. Although chemotherapy has existed for many decades,…

Can Melanoma Be Found Early? Melanoma is one of the most common cancers diagnosed in the United States and the…